138 related articles for article (PubMed ID: 1319460)
21. Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
Chodosh S
Chest; 1991 Dec; 100(6):1497-502. PubMed ID: 1659975
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
Mazzei T; Cassetta MI; Fallani S; Arrigucci S; Novelli A
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S35-41. PubMed ID: 16829051
[TBL] [Abstract][Full Text] [Related]
23. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
Parish LC; Jungkind DL
Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
[TBL] [Abstract][Full Text] [Related]
24. Clinical inquiries. Which UTI therapies are safe and effective during breastfeeding?
Kaiser J; McPherson V; Kaufman L; Huber T
J Fam Pract; 2007 Mar; 56(3):225-8. PubMed ID: 17343814
[No Abstract] [Full Text] [Related]
25. Efficacy of temafloxacin versus ciprofloxacin or amoxicillin for lower respiratory tract infections in smokers and the elderly.
Davey PG
Am J Med; 1991 Dec; 91(6A):101S-105S. PubMed ID: 1662877
[TBL] [Abstract][Full Text] [Related]
26. The expanding role of fluoroquinolones.
Schaeffer AJ
Am J Med; 2002 Jul; 113 Suppl 1A():45S-54S. PubMed ID: 12113871
[TBL] [Abstract][Full Text] [Related]
27. Chancroid and TMP-SMX.
AIDS Patient Care STDS; 1996 Feb; 10(1):53. PubMed ID: 11361672
[No Abstract] [Full Text] [Related]
28. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
Kosmidis J
J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
[TBL] [Abstract][Full Text] [Related]
29. Treatment of ciprofloxacin nonsusceptible urinary tract infections with ciprofloxacin.
Jeffres MN; Shuster JE; Barclay SM
Ann Pharmacother; 2011 Jun; 45(6):824-5. PubMed ID: 21666093
[No Abstract] [Full Text] [Related]
30. Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women?
Rosenbaum D; Luther S; Krist A
J Fam Pract; 2000 Jun; 49(6):573-4. PubMed ID: 10923561
[No Abstract] [Full Text] [Related]
31. Uncomplicate the treatment of uncomplicated urinary tract infections.
Ditmanson LF; Apgar DA
Arch Intern Med; 1996 Jan; 156(1):111-3. PubMed ID: 8526690
[No Abstract] [Full Text] [Related]
32. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
33. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.
Karaca Y; Coplu N; Gozalan A; Oncul O; Citil BE; Esen B
Int J Antimicrob Agents; 2005 Jul; 26(1):75-7. PubMed ID: 15955672
[TBL] [Abstract][Full Text] [Related]
34. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Chodosh S
Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900
[TBL] [Abstract][Full Text] [Related]
35. Urinary tract infection: emerging insights into appropriate management.
Williams DN
Postgrad Med; 1996 Apr; 99(4):189-92, 198-9, 201 passim. PubMed ID: 8604406
[TBL] [Abstract][Full Text] [Related]
36. [Microbiological evaluation of ciprofloxacin efficacy for treatment of urinary tract infections].
Kalisz J; Denys A; Szczerba W; Rusinek A; Rogowska-Kalisz A
Med Dosw Mikrobiol; 1996; 48(3-4):169-75. PubMed ID: 9182138
[TBL] [Abstract][Full Text] [Related]
37. [Dysuria].
Barwitz HJ
MMW Fortschr Med; 2003 Sep; 145(39):57-8. PubMed ID: 14649083
[No Abstract] [Full Text] [Related]
38. Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?
Miller LG; Mehrotra R; Tang AW
Int J Antimicrob Agents; 2007 May; 29(5):605-7. PubMed ID: 17293087
[No Abstract] [Full Text] [Related]
39. Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infection.
Naber KG; Landen H
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S35-40. PubMed ID: 15037327
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection.
Naber KG; di Silverio F; Geddes A; Guibert J
J Antimicrob Chemother; 1996 May; 37 Suppl A():135-44. PubMed ID: 8737133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
